STOCK TITAN

Park Dental Partners Announces First Quarter 2026 Results

(Moderate)
(Neutral)
Tags

Park Dental Partners (NASDAQ:PARK) reported Q1 2026 revenue of $62.7 million, up 6.2% year over year, with same practice revenue growth of 4.1%.

The company recorded a net loss of $0.4 million, adjusted EBITDA of $4.7 million, strong cash of $24.4 million, and reaffirmed its 2026 revenue outlook of $254–$258 million and adjusted EBITDA of $21–$23 million.

Loading...
Loading translation...

Positive

  • Revenue increased 6.2% year over year to $62.7 million
  • Same practice revenue growth reached 4.1%
  • Adjusted gross margin rose to $12.2 million, up 2.6%
  • Practicing affiliated doctors increased 8.9% to 221
  • Operating cash flow was $5.0 million in Q1 2026
  • Cash of $24.4 million and undrawn $15 million credit line
  • Maintained full-year 2026 revenue outlook of $254–$258 million
  • Maintained 2026 adjusted EBITDA outlook of $21–$23 million

Negative

  • Net result shifted to a $0.4 million loss from $1.6 million income
  • Gross margin declined to $6.4 million, down 35.3%
  • Gross margin percentage fell to 10.2% from 16.7%
  • Adjusted EBITDA decreased 13.2% to $4.7 million
  • Adjusted EBITDA margin declined to 7.6% from 9.3%
  • Diluted EPS moved to ($0.09) from $0.88
  • Adjusted diluted EPS fell to $0.44 from $1.14
  • Operating cash flow decreased by $0.8 million year over year

News Market Reaction – PARK

-1.75%
2 alerts
-1.75% Session close to close
$88.38M Market Cap
0.4x Rel. Volume

In the May 14 session, PARK declined 1.75%, reflecting a mild negative market reaction. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement details Q1 2026 performance, with revenue rising to $62.7M but gross margin compre...
Analysis

This announcement details Q1 2026 performance, with revenue rising to $62.7M but gross margin compressing to 10.2% and results shifting to a $0.4M net loss. Adjusted EBITDA of $4.7M and reaffirmed 2026 guidance of $254.0–$258.0M revenue and $21.0–$23.0M adjusted EBITDA highlight continued growth ambitions. Investors may watch margin trends, cash generation, acquisition integration and execution against same-practice growth targets.

Key Figures

Q1 2026 Revenue: $62.7M Q1 2026 Gross Margin %: 10.2% Q1 2026 Net Income (Loss): ($0.4M) +5 more
8 metrics
Q1 2026 Revenue $62.7M Three months ended March 31, 2026 vs $59.0M in Q1 2025 (6.2% growth)
Q1 2026 Gross Margin % 10.2% Down from 16.7% in Q1 2025 (650 bps decline)
Q1 2026 Net Income (Loss) ($0.4M) Compared to $1.6M net income in Q1 2025
Q1 2026 Adjusted EBITDA $4.7M Versus $5.5M in Q1 2025; margin 7.6% vs 9.3%
Cash and Equivalents $24.4M Balance as of March 31, 2026
Total Debt $11.5M Debt outstanding as of March 31, 2026
2026 Revenue Outlook $254.0–$258.0M Guidance vs $244.5M actual revenue in 2025 (mid-single-digit growth)
2026 Adjusted EBITDA Outlook $21.0–$23.0M Guidance vs $22.0M actual adjusted EBITDA in 2025

Historical Context

5 past events · Latest: Apr 24 (Neutral)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Apr 24 Earnings call timing Neutral +1.5% Announced timing for Q1 2026 earnings release and conference call.
Feb 25 Full-year results Negative -4.5% Reported 2025 revenue growth but a swing to GAAP net loss and weaker Q4.
Jan 30 Earnings call timing Neutral +5.8% Set dates for Q4 and full-year 2025 earnings release and webcast.
Jan 29 Annual meeting date Neutral -5.7% Announced date for the 2026 annual shareholders meeting.
Jan 28 Practice acquisition Positive +2.7% Expanded network with Ironwood Dental affiliation in Tucson, Arizona.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Stock reactions have generally aligned with the tone of prior news, with GAAP-weak earnings drawing pressure and growth or expansion updates seeing constructive responses.

Recent Company History

Over the last six months, Park Dental Partners has moved from its December IPO into a regular earnings and governance cadence. The company reported 2025 results with revenue of $244.5M and guided 2026 revenue to $254.0–$258.0M. It expanded in Arizona via the Ironwood Dental affiliation and set dates for earnings calls and its first annual meeting. Today’s Q1 2026 report builds directly on that guidance and recent acquisition activity.

Key Terms

diluted eps, adjusted gross margin, adjusted ebitda, adjusted diluted eps, +4 more
8 terms
diluted eps financial
"Diluted EPS | ($0.09) | | $0.88 | | ($0.97)"
Diluted earnings per share (EPS) shows how much profit a company makes for each share of stock, assuming all possible shares from stock options or convertible securities are used. It provides a more conservative estimate than basic EPS, accounting for potential share increases that could dilute ownership. Investors use diluted EPS to get a clearer picture of a company's true profitability on a per-share basis.
adjusted gross margin financial
"Adjusted Gross Margin (a) | $12.2 | | $11.9 |"
Adjusted gross margin is a measure of how much profit a company makes from its sales after accounting for certain expenses or one-time costs, but before deducting other operating expenses. It helps investors see the company's core profitability more clearly by removing factors that might distort the usual profit picture, similar to a runner measuring their speed without considering obstacles or weather. This metric provides a clearer view of the company's ongoing financial health.
adjusted ebitda financial
"Adjusted EBITDA ( b ) | $4.7 | | $5.5 |"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
adjusted diluted eps financial
"Adjusted Diluted EPS ( c ) | $0.44 | | $1.14 |"
Adjusted diluted EPS is a company’s profit per share after adding back or removing one-time items (like restructuring costs or gains) and dividing by the number of shares including potential shares from options and convertible securities. Investors use it as a cleaner view of ongoing earnings—like looking at a car’s regular fuel efficiency rather than a trip boosted by downhill coasting—to judge underlying performance and compare companies without temporary distortions.
same practice revenue growth financial
"Same Practice Revenue Growth | | 4.1% | | 1.2%"
Same practice revenue growth measures how much revenue has risen or fallen at medical or professional practices that were operating in both the current and prior reporting periods, excluding income from newly acquired or newly opened locations. Think of it like comparing sales at the same set of stores instead of counting results from fresh storefronts; it tells investors whether existing operations are gaining patients, charging more, or improving efficiency, and thus reveals the business’s organic performance apart from expansion.
operating cash flow financial
"We generated $5.0 million in operating cash flow in the first quarter"
Operating cash flow is the amount of money a company earns from its main business activities, like selling products or services. It shows how well the company can generate cash to pay bills, invest in growth, or return money to shareholders. This figure helps investors understand if the company’s core operations are healthy and sustainable.
View in glossary
line of credit financial
"our $15 million line of credit was undrawn at quarter end"
A line of credit is a flexible borrowing arrangement that lets a company draw money up to a preset limit, repay it, and borrow again as needed—similar to a business credit card or an emergency tap on a savings account. It matters to investors because it shows how a firm manages short-term cash needs and growth funding without taking a single large loan; access, cost, and attached conditions can affect liquidity, interest expenses and financial risk.
initial public offering financial
"shares issued and vested during the IPO."
An initial public offering (IPO) is when a private company first sells its shares to the public and becomes a stock-listed company. It matters because it allows the company to raise money from a wide range of investors, helping it grow, while giving early shareholders a way to sell some of their ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

MINNEAPOLIS, May 13, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK) and affiliated dental practices (“Park Dental Partners,” “we,” “our,” “us,” or the “Company”) today reported its first-quarter financial results for 2026.   Summary financial results are listed below and in the accompanying supplemental financial tables.

(Unaudited, in millions, except per share data, and Doctor counts)
 Three Months Ended
March 31,
 
 2026
   2025 Change
 
Revenue$62.7
  $59.0
 6.2%
 
Gross Margin$6.4
  $9.9
 (35.3%)
 
Gross Margin percentage 10.2%   16.7% (650 bps) 
Net Income (Loss)($0.4)
  $1.6
 (124.9%)
 
Diluted EPS($0.09)
  $0.88
 ($0.97)
 
         
Adjusted Gross Margin(a)$12.2
  $11.9
 2.6%
 
Adjusted Gross Margin Percentage(a) 19.5%   20.2% (70 bps) 
Adjusted EBITDA(b)$4.7
  $5.5
 (13.2%)
 
Adjusted EBITDA margin(b) 7.6%   9.3% (170 bps) 
Adjusted Diluted EPS(c)$0.44
  $1.14
 ($0.70)
 
      
Same Practice Revenue Growth 4.1%   1.2% 290 bps
 
Practicing Affiliated Doctors 221   203 8.9% 

      
(a)   See Non GAAP Reconciliation of Gross Margin to Adjusted Gross Margin below
(b)   See Non GAAP Reconciliation of Net Income (Loss) to Adjusted EBITDA below
(c)   See Non GAAP Reconciliation of Earnings (Loss) Per Share to Adjusted Earnings Per Share below


Executive Commentary – Pete Swenson, Chief Executive Officer and Chair of the Board of Directors

“We delivered a solid start to 2026, with revenue increasing 6.2% year over year, driven by strong same practice performance and continued patient demand. Results were consistent with our expectations and reflect continued execution against our operating plan. We continue to invest in recruiting, staffing, and clinical capacity to support long-term growth.

With strong liquidity and a flexible balance sheet, we remain well positioned to execute on our growth strategy, including expanding current practices and adding new practices through disciplined acquisitions and de novo expansion.”

Financial Results – First Quarter 2026

  • Revenue increased 6.2% over the prior year’s comparable quarter to $62.7 million, due to increased patient visits and growth in clinical hours, the impact of acquisitions and reimbursement growth. Same practice revenue growth was 4.1%. Revenue from acquisitions in the past 12 months contributed approximately $0.8 million in the quarter.
  • Total General Practice revenue grew 6.4% over the prior year’s comparable quarter to $46.1 million. Total Multi-Specialty Practice revenue grew 5.7% to $16.6 million.
  • Cost of services was $56.3 million, an increase of $7.1 million above the prior year’s comparable quarter, driven primarily by share-based compensation recorded in the quarter and growth in doctors and team members.
  • General and administrative costs were $7.8 million, an increase of $0.9 million above the prior year’s comparable quarter. The primary driver of these increases was share-based compensation, acquisition-related costs, and public company costs, net of lower IPO preparation costs related to our 2025 offering.
  • Net loss was $(0.4) million, compared to net income of $1.6 million in the prior year comparable quarter, primarily driven by increased salaries and benefits, and share-based compensation, partially offset by revenue growth, tax benefits on share-based compensation, and operating leverage.
  • Adjusted EBITDA was $4.7 million, or 7.6% of revenue, compared to $5.5 million, or 9.3% of revenue in the prior year comparable quarter.
  • Adjusted diluted earnings per share were $0.44 versus $1.14 in the prior year’s comparable quarter, due primarily to the increase in shares issued and vested during the IPO.

Affiliated Practice Updates

  • As of March 31, 2026, we supported 86 affiliated practices and 221 affiliated doctors.
  • First quarter patient retention rate was 90.1%.
  • Patient visits increased to 178,527 across our affiliated dental practices.
  • During the first quarter our affiliated dental practices completed one general practice acquisition in Tucson, Arizona, as previously announced on January 23, 2026. The acquired practices’ impact on revenues and net earnings was not material for the quarter.

Balance Sheet, Liquidity, and Cash Flow

  • Cash and cash equivalents were $24.4 million as of March 31, 2026.
  • Total debt outstanding was approximately $11.5 million as of March 31, 2026, and our $15 million line of credit was undrawn at quarter end.
  • Total shares outstanding were 4.5 million shares as of the end of the quarter.
  • We generated $5.0 million in operating cash flow in the first quarter, a decrease of $0.8 million compared to the prior year comparable quarter due primarily to changes in working capital.
  • First quarter capital investments were $2.3 million.

Full-Year 2026 Outlook

First quarter results were consistent with our expectations, and we are maintaining our fiscal 2026 outlook range. Our outlook excludes the impact of any future practice affiliations or acquisitions that have not yet closed. As a result, actual results may differ materially depending on the timing and number of future affiliations, de novo practice openings, or acquisitions completed during the year.

      
 Year Ending Year Ended Percent
 December 31, 2026 December 31, 2025 Change
($ in millions)(Outlook) (Actual) (At Midpoint)
Revenue$254.0$258.0 $244.5
 4.7%
Adjusted EBITDA$21.0$23.0 $22.0
 -
Adjusted EBITDA margin8.3% - 8.9% 9.0%
  


Our outlook includes 3.5% to 5.0% same practice revenue growth and approximately $2 million recurring public company costs we expect to incur in 2026. The outlook assumes continued patient demand across general and specialty services, stable reimbursement trends across commercial and government payors, ongoing recruitment and retention initiatives, and contributions from recently acquired and affiliated practices and de novos. We continue to monitor patient demand and labor market trends that could impact our outlook.

Conference Call

As announced on April 24, 2026, the Company will host a conference call to discuss these results tomorrow morning, Thursday, May 14, 2026, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time).

A live webcast of the call will be accessible by registering using the link below or through the Investor Relations section of the Company’s website at https://investors.parkdentalpartners.com. A replay of the webcast will be available on the website for a limited time following the call.

About Park Dental Partners, Inc.

Park Dental Partners, Inc., and its subsidiaries (NASDAQ:PARK) is a dental resource organization that has put patients first since the establishment of its general dentistry group in 1972. The Company provides comprehensive business support services, including clinical team members, administrative personnel, facilities, and equipment, to its affiliated general and multi-specialty dental practices. The Company has 221 affiliated doctors across 86 practice locations in three states. The Company’s clinical support team consists of approximately 990 hygienists, dental assistants, and patient care coordinators that support affiliated doctors in operating their practices. The mission of our affiliated dental practices since inception has been to ensure patients enjoy the benefits of a lifetime of good oral health. This mission continues to be the driving force behind our organization today.

Park Dental Partners is based in Roseville, Minnesota. For more information, please visit parkdentalpartners.com.

Basis of Consolidation

In accordance with generally accepted accounting principles in the United States, we consolidate the net assets and results of operations of the affiliated dental practices operating under long-term administrative resource agreements with us. As a result, references to our revenues, our expenses and similar items relating to our results of operations and net assets includes the revenues, expenses and similar items of our affiliated dental practices and all transactions between the affiliated dental practices and us, such as the service fees we charge, are eliminated in consolidation.

Forward Looking Statements

Certain statements in this press release are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, with respect to the Company’s financial condition, results of operations, plans, objectives, future performance and business. Forward-looking statements include those preceded by, followed by or that include the words “believes,” “expects,” “anticipates,” “intends,” “estimates,” “plans,” “may,” “will,” or similar expressions. These forward-looking statements involve risks and uncertainties. Actual results may differ materially from those contemplated by such forward-looking statements because of, among other things, potential risks and uncertainties, such as:

  • Regulatory and compliance risk, including state dental corporate practice of dentistry and fee-splitting restrictions, HIPAA and other privacy/cybersecurity obligations, and evolving healthcare and labor regulations;
  • Reimbursement risk, including risks related to payer mix, reimbursement rates, audit/recoupment activity, enrollment and collections timing, and dependence on significant third-party payors;
  • Our ability to identify, acquire, integrate and effectively support affiliated practices and to execute de novo expansion, and the risk of undiscovered liabilities in acquisitions;
  • Dependence on affiliated dental practices and their clinical performance; our ability to attract, hire and retain dentists, specialists and hygienists; and risks related to ownership transitions of affiliated entities;
  • Competition for patients and clinicians in our markets and the impact on patient volumes and staffing;
  • Macroeconomic conditions, inflation and interest rates, and our geographic concentration, particularly in the markets we operate.

A forward-looking statement is neither a prediction nor a guarantee of future events or circumstances, and those future events or circumstances may not occur. We are under no obligation, and we expressly disclaim any obligation, to update or alter any forward-looking statements, whether because of new information, future events or otherwise.

Non-GAAP Financial Measures

This news release and the related conference call include presentation of Non-GAAP measures that include or exclude special items of a nonrecurring and/or nonoperational nature. Management believes that the Non-GAAP measures provide useful information to investors regarding the Company’s results of operations and financial condition because they permit a more meaningful comparison and understanding of Park Dental Partners, Inc’s operating performance for the current, past or future periods. Management uses these Non-GAAP measures to monitor and evaluate ongoing operating results and trends and to gain an understanding of the comparative operating performance of the Company.

Please note that the Company has not provided the most directly comparable GAAP financial measure, or a quantitative reconciliation thereto, for the Adjusted EBITDA forward-looking guidance for 2026 included in this press release in reliance on the unreasonable efforts exception provided under Item 10(e)(1)(i)(B) of Regulation S-K. Providing the most directly comparable GAAP financial measure, or a quantitative reconciliation thereto, cannot be done without unreasonable effort due to the inherent uncertainty and difficulty in predicting certain non-cash, material and/or non-recurring expenses or benefits; legal settlements or other matters; and certain tax positions. The variability of these items could have an unpredictable, and potentially significant, impact on our future GAAP financial results.

See Supplemental non-GAAP financial tables below for a reconciliation of adjusted non-GAAP financial measures to GAAP.

Supplemental Financial Tables 

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES 
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) 
(in thousands, except share and per share amounts) 
        
        
  Three Months Ended March 31, 
  2026     2025  
REVENUE    $62,695  $59,037  
COST OF SERVICES       
Salaries and benefits  41,895   35,637  
Dental supplies and Laboratory fees  4,338   4,239  
Office occupancy  4,285   4,004  
Other practice expenses  3,834   3,405  
Depreciation  1,963   1,896  
TOTAL COST OF SERVICES  56,315   49,181  
GROSS MARGIN  6,380   9,856  
General and administrative expenses  7,840   6,928  
Depreciation and amortization  420   378  
OPERATING INCOME (LOSS)  (1,880)  2,550  
INTEREST EXPENSE - NET  (121)  (337) 
INCOME (LOSS) BEFORE TAX  (2,001)  2,213  
PROVISION/(BENEFIT) FOR INCOME TAX  (1,611)  646  
NET INCOME (LOSS) $(390) $1,566  
EARNINGS (LOSS) PER SHARE:       
Basic $(0.09) $0.88  
Diluted $(0.09) $0.88  
Basic weighted-average number of common shares outstanding  4,383,073   1,783,352  
Diluted weighted-average number of common shares outstanding  4,383,073   1,783,352  
        



PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES 
CONDENSED CONSOLIDATED BALANCE SHEET (unaudited) 
(in thousands) 
        
     At March 31,     At December 31,  
  2026 2025 
ASSETS         
Cash and cash equivalents $24,372 $25,185 
Accounts receivable – net of allowance  6,819  6,991 
Other current assets  6,531  5,726 
Total current assets  37,722  37,902 
OTHER ASSETS:         
Property and equipment and lease assets  73,945  73,828 
Goodwill and Intangible assets, nets  29,793  28,360 
Other assets  38,397  38,093 
Total other assets  142,135  140,281 
TOTAL ASSETS $179,857 $178,183 
LIABILITIES AND DEFICIT         
Accounts payable and other accrued liabilities $6,682 $6,291 
Payroll, benefits and short term deferred compensation  16,802  16,716 
Current portion of debt and lease liabilities  8,730  8,606 
Deferred Revenue and other current liabilities  3,084  4,120 
Total current liabilities  35,298  35,733 
LONG-TERM LIABILITIES:         
Deferred compensation  67,569  68,417 
Long-term debt and lease liabilities  51,016  51,744 
Other long-term liabilities  537  486 
Total long-term liabilities  119,122  120,647 
TOTAL LIABILITIES $154,420 $156,380 
Total shareholders’ equity $25,437 $21,803 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $179,857 $178,183 
        



PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)
(in thousands)
       
  For the Three Months Ended
  March 31, 
     2026     2025 
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net income (loss) $(390) $1,566 
Adjustments to reconcile net income (loss) to net cash flows from operating activities:      
Depreciation and amortization  2,383   2,274 
Deferred income taxes  (470)   
Change in cash surrender value of life insurance  440   335 
Noncash lease and loss on disposal of equipment  31   (15)
Share based compensation  4,024    
Changes in operating assets and liabilities  (992)  1,699 
Net cash flows from operating activities  5,026   5,859 
NET CASH FLOWS USED IN INVESTING ACTIVITIES:        
Purchases of property and equipment $(2,305) $(2,420)
Life insurance premiums paid  (273)  (664)
Payments for purchases of dental practices  (1,595)   
Issuance of notes to related parties  (600)   
Net cash flows used in investing activities  (4,773)  (3,084)
CASH FLOWS USED IN FINANCING ACTIVITIES:        
Dental practice purchase installment payments $(8) $(8)
Net change in checks issued in excess of cash balances  (573)  (1,328)
Net proceeds (payments) on debt and capital leases  (485)  (489)
Cash paid for Share Repurchase     (154)
Net cash flows used in financing activities  (1,066)  (1,979)
NET CHANGE IN CASH AND CASH EQUIVALENTS  (813)  796 
CASH AND CASH EQUIVALENTS – Beginning of year  25,185   2,672 
CASH AND CASH EQUIVALENTS - End of year $24,372  $3,468 
       



PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES 
RECONCILIATION OF GROSS MARGIN TO ADJUSTED GROSS MARGIN (unaudited) 
(in thousands) 
            
            
     Three Months Ended March 31, 
  2026  2025  
GROSS MARGIN $6,380 10.2% $9,856 16.7% 
Addback:           
Share based compensation  3,665 5.8%  - 0.0% 
Restructuring costs1  37 0.1%  63 0.1% 
Deferred compensation  160 0.3%  85 0.1% 
Depreciation  1,963 3.1%  1,896 3.2% 
ADJUSTED GROSS MARGIN $12,205   $11,900   
ADJUSTED GROSS MARGIN PERCENTAGE    19.5%    20.2% 
            
            
            
            
1 Restructuring costs primarily consist of expenses incurred in connection with the Company’s initial public offering.    
            



PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES
RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED EBITDA (unaudited)
(in thousands)
           
  For the Three Months Ended
  March 31, 
     2026       2025  
NET INCOME (LOSS) $(390) (0.6%) $1,566 2.7%
Addback:          
Provision/(Benefit) for income tax  (1,611) (2.6%)  646 1.1%
Interest expense, net  121  0.2%  337 0.6%
Depreciation and amortization  2,383  3.8%  2,274 3.9%
EBITDA $503  0.8% $4,823 8.2%
Adjustments:          
Share based compensation  4,024  6.4%  - 0.0%
Restructuring costs1  58  0.1%  557 0.9%
Deferred compensation  160  0.3%  85 0.1%
ADJUSTED EBITDA $4,745  7.6% $5,465 9.3%
           
           
           
           
1 Restructuring costs primarily consist of expenses incurred in connection with the Company’s initial public offering.  
           



PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES
RECONCILIATION OF EARNINGS (LOSS) PER SHARE TO ADJUSTED EARNINGS PER SHARE (unaudited)
(in thousands, except share and per share amounts)
       
  For the Three Months Ended
  March 31, 
     2026     2025 
EARNINGS (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS: $(390) $1,566 
Adjustments:      
Share based compensation  4,024   - 
Restructuring costs  58   557 
Deferred compensation  160   85 
Income tax effect of the Adjustments1  (1,188)  (180)
ADJUSTED NET INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS $2,664  $2,028 
       
       
Adjusted Weighted Average Diluted Shares - Reconciliation      
WEIGHTED-AVERAGE SHARES USED IN COMPUTING GAAP NET LOSS PER SHARE, DILUTED  4,383,073   1,783,352 
ADJUSTED WEIGHTED AVERAGE DILUTED SHARES USED IN COMPUTING ADJUSTED EARNINGS PER SHARE, DILUTED2  6,059,839   1,783,352 
       
ADJUSTED DILUTED EARNINGS PER SHARE: $0.44  $1.14 
       
       
       
 
1 Income tax effect is based on an estimated long-term annual effective tax rate of 28% tax rate for the three months ended March 31, 2026 and March 31, 2025. The Company's estimated long-term annual effective tax rate excludes certain non-cash items such as share based compensation arrangements, and is used in order to provide consistency accross periods.
2 Includes an additional 1,584,666 of weighted average dilutive shares and 92,100 of weighted average dilutive warrants for the three months ended March 31, 2026, that are excluded from a GAAP perspective due to the Company's net loss in that reporting period.
       



PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES
CONSOLIDATED OPERATING METRICS (unaudited)
 
  For the Three Months Ended
  March 31,
     2026
    2025
      
Patient Visits1 178,527
  175,940
Same Practice Revenue Growth2 4.1%
  1.2%
Patient Retention Rate3 90.1%
  89.2%
Doctor Count4 221
  203
      


1 A patient visit is counted when service is provided to a patient at one of our affiliated dental general dentistry practices. Measuring the year-over-year change in patient visits helps us to evaluate how the affiliated dental practices are performing. It also helps with evaluating demand for services which influences decision-making relating to matters such as appropriate staffing levels and recruiting needs. In addition, it influences decision-making processes relating to our marketing, sales and advertising strategies and helps us with evaluating the effectiveness of those strategies. Further, with respect to continuing care patient count, it allows us to evaluate the ability of affiliated dentists to encourage patients to complete their diagnosed dental treatment plans.
 
2 Same practice revenues represent total revenues for same dental practice locations that have been operating for at least 13 full months prior to the end of a given reporting period and which have not been closed, or sold during such period. Measuring the year-over-year change in same practice revenues allows us to evaluate how affiliated dental practices are performing. We believe various factors affect comparable practice revenues, including patient demand for dental services, economic trends, dentist and hygienist staffing levels, availability of dentists and hygienists, pricing, competition, visibility and accessibility of the dental practices, quality of the tenants surrounding the dental practices, clinical hours and the level of patient service provided inside and outside of the dental practices.
 
3 Patient retention rate is calculated by counting patients that remain active at the beginning and end of a twelve-month period. Active patients are defined as general dentistry patients having been seen by our affiliated dental practices within the past 36 months, or last 18 months for patients under the age of 18. Patients who have not been seen by our affiliated dental practices within these time periods are removed from our active patient lists. This methodology is aligned with ADA clinical procedure codes, and is consistent with treatment protocols for new patients, before being considered an active patient again. Measuring the year-over-year and quarter-over-quarter change in patient retention allows us to evaluate the recurring nature of patient visits at the dental practices and affiliated dentists which influences decision-making around matters such as appropriate levels of staffing, recruiting, advertising and facility expansion opportunities.
 
4 Dentists operating in one of our affiliated dental practices are included in this calculation, which includes both full and part-time dentists. Measuring the year-over-year and quarter-over- quarter change in dentist count allows us to evaluate the production capacity of affiliated dental practices. It also influences decision-making relating to matters such as appropriate staffing levels and recruiting needs.




Company Contact Information
Investor Contact:
Park Dental Partners Investor Relations Team
763-233-3377
ir@parkdentalpartners.com

Media Contact:
Park Dental Partners Media Relations Team
651-633-0500
marketing@parkdentalpartners.com

FAQ

How did Park Dental Partners (PARK) perform in Q1 2026?

Park Dental Partners posted higher revenue but lower profitability in Q1 2026. According to Park Dental Partners, revenue rose 6.2% to $62.7 million, while the company reported a net loss of $0.4 million and adjusted EBITDA of $4.7 million.

What was Park Dental Partners' Q1 2026 same practice revenue growth?

Park Dental Partners reported same practice revenue growth of 4.1% in Q1 2026. According to Park Dental Partners, this growth was supported by increased patient visits, expanded clinical hours, and continued demand across general and multi-specialty services at its affiliated practices.

What is Park Dental Partners' full-year 2026 outlook for revenue and EBITDA?

Park Dental Partners reaffirmed its 2026 guidance for modest revenue growth with stable EBITDA. According to Park Dental Partners, it expects 2026 revenue of $254–$258 million and adjusted EBITDA of $21–$23 million, implying an adjusted EBITDA margin of 8.3%–8.9%.

How strong is Park Dental Partners' balance sheet and liquidity after Q1 2026?

Park Dental Partners reported a conservative leverage and liquidity position at Q1 2026. According to Park Dental Partners, cash and equivalents were $24.4 million, total debt was about $11.5 million, and its $15 million revolving credit facility remained fully undrawn.

Did Park Dental Partners complete any acquisitions in Q1 2026?

Park Dental Partners completed one general practice acquisition in Tucson, Arizona, during Q1 2026. According to Park Dental Partners, this previously announced transaction had an immaterial impact on quarterly revenue and net earnings but adds to its network of 86 affiliated practices.

How many affiliated doctors and patient visits did Park Dental Partners report for Q1 2026?

Park Dental Partners expanded its network and patient volume in Q1 2026. According to Park Dental Partners, it supported 221 affiliated doctors across 86 practices and recorded 178,527 patient visits, with a first-quarter patient retention rate of 90.1%.

When is the Park Dental Partners (PARK) Q1 2026 earnings conference call?

Park Dental Partners scheduled its Q1 2026 earnings call for May 14, 2026, at 8:30 a.m. Eastern Time. According to Park Dental Partners, investors can access a live webcast and replay through the investor relations section of its website.